Please Wait...

Congressman Patrick Meehan Visits Bioclinica

Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices

Bioclinica was honored to host Congressman Patrick Meehan representing the 7th Congressional District in Pennsylvania in a visit to our Audubon, Pennsylvania offices on August 28. Congressman Meehan met with Bioclinica senior leadership, including our CEO Dr. John Hubbard, who is the 2017 Chairman of the Association of Clinical Research Organizations (ACRO), joined by ACRO Executive Director Douglas Peddicord. The discussion provided a view into the biopharma industry and Bioclinica’s role in advancing drug development by employing an approach that combines science and technology.

 

 

Congressman Patrick Meehan visits with Bioclinica staff joined by ACRO Executive Director Douglas Peddicord

During his visit, Congressman Meehan also participated in a town hall gathering with staff, many of whom reside within his district covering parts of southeastern Pennsylvania. "The life sciences industry is making a significant economic impact in our region as well as important contributions globally in people's health," said Congressman Meehan. "I appreciate this opportunity to see Bioclinica's operation, innovation, and remarkable work you do in bringing new cures to people in need."

 

 

Congressman Meehan hears from Bioclinica CEO John Hubbard, PhD and other company executives about Bioclinica's contributions, leading to new cures

Dr. Hubbard recognized Congressman Meehan's ongoing support of the biopharma industry and representation on Capitol Hill saying, "We appreciate all you do in support of our challenges and opportunities in the development of new cures." One such effort was the introduction of the Domestic Research Enhancement Act of 2017 with co-sponsors Rep George Holding and G.K. Butterfield of North Carolina. The Act modernizes the research and development tax credit to recognize the essential role contract research plays in the development of new pharmaceuticals, biologics, and medical devices.

Category: 

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Come talk to Bioclinica at #ASCO19! See why we're the world leader in #oncology imaging, helping to assess efficacy… https://t.co/MyomMS0Rvt
Bioclinica (2 days ago)
Great insights for sponsors conducting #NAFLD #NASH #clinicaltrials. https://t.co/TG1WwRhVE8
Bioclinica (3 days ago)
In Beijing for DIA China next week? If so, drop by Bioclinica's exhibit or catch our talk in the Randomization & Cl… https://t.co/LCNpNHabo2
Bioclinica (4 days ago)
Greetings from Milan! Bioclinica looks forward to connecting with our #pharma and #CRO friends at #octEurope! Raggy… https://t.co/KqG99HqDWA
Bioclinica (5 days ago)
Could EDC software be a game changer in your clinical trial? Here's what to look for in evaluating different syste… https://t.co/MyxooYMwqk
Bioclinica (5 days ago)
This week at OCT Europe, #pharma #CRO companies can get a look at Bioclinica's award-winning clinical adjudication… https://t.co/jzEexOMDZA
Bioclinica (6 days ago)

Latest Blogs:

Medical Imaging of Non-Alcoholic Fatty Liver Diseases in Clinical Trials
EDC Provider Selection
Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box